Dear Sir,
We read with great interest the letter from Laffon et al. [1] in which the authors refer to a recently published paper of our group that evaluates the factors affecting 2-deoxy-2-(18F)-fluoro-D-glucose (18F-FDG) uptake in the liver and mediastinum during chemotherapy (CHT) in Hodgkin’s lymphoma (HL) [2]. Laffon et al. suggest that the total amount of uptake in malignant tissues of cancer patients may play a role in the reduction of 18F-FDG uptake in the liver at staging in HL (as shown in the report previously cited) [2, 3]. For this reason, the authors suggest that the measurement of the total 18F-FDG that is irreversibly trapped in a pathological tissue (as measured by a formula suggested by Laffon et al. [3]) could help in the explanation of this phenomenon and could be useful when evaluating positron emission tomography/computed tomography (PET/CT) scans of patients with cancer.
We agree with the hypothesis of Laffon and colleagues. We performed a further analysis of the data already published [2], and here we report a graphical representation of the relationship between the maximum standardized uptake value (SUVmax) in the mediastinum and the stage of the disease (Fig. 1) that led to results similar to those observed in the liver [2]. In particular, in our study cohort, the SUVmax in the mediastinum is significantly related to the extension of HL according to Ann Arbor criteria with a lower SUVmax in the mediastinum being related to a higher stage of the disease (p = 0.0385, Fig. 1) [2]. In agreement with Laffon et al., we can conclude that when a tissue shows an intense tracer uptake, the amount of tracer available to another tissue is reduced (to be specific, the circulating 18F-FDG in the blood as detectable by means of mediastinum SUVmax) [4]. We would like to thank Laffon et al. for their detailed comments and suggestions that have greatly improved the results of our study.
References
Laffon E, de Clermont H, Lamare F, Marthan R. Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship. Eur J Nucl Med Mol Imaging 2014. doi:10.1007/s00259-014-2925-1.
Chiaravalloti A, Danieli R, Abbatiello P, Di Pietro B, Travascio L, Cantonetti M, et al. Factors affecting intrapatient liver and mediastinal blood pool (18)F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 2014;41:1123–32. doi:10.1007/s00259-014-2703-0.
Laffon E, de Clermont H, Lamare F, Marthan R. Estimating the amount of FDG uptake in physiological tissues. Nucl Med Biol 2014;41:717–20.
Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009;50:11S–20S.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiaravalloti, A., Schillaci, O. Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship. Eur J Nucl Med Mol Imaging 42, 166 (2015). https://doi.org/10.1007/s00259-014-2926-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-014-2926-0